Clik here to view.
Zai Lab-Supported Study Published in Cell Provides New Insights with...
SHANGHAI & CAMBRIDGE, Mass. Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that data published in the journal Cell demonstrate that neoadjuvant monotherapy with the poly (ADP-ribose)...
View ArticleClik here to view.
Orum Therapeutics Announces a Global, Multi-Target License and Option...
BOSTON & DAEJEON, South Korea Orum Therapeutics (“Orum” or the “Company”), a clinical-stage private biotechnology company pioneering the field of degrader-antibody conjugates (DACs), today...
View ArticleClik here to view.
SOTIO Enters into Multi-Target Antibody Agreement with Biocytogen to Expand...
PRAGUE & BEIJING SOTIO Biotech, a clinical-stage biopharmaceutical company owned by PPF Group, and Biocytogen (HKEX: 02315), a global biotech company focused on the discovery of novel antibody...
View ArticleClik here to view.
SOTIO与百奥赛图达成多靶点抗体合作协议，扩大ADC产品管线
捷克共和国布拉格和中国北京 (美国商业资讯)– SOTIO Biotech，一家PPF集团旗下的临床阶段生物制药公司和百奥赛图（HKEX: 02315），一家专注于新型抗体类药物发现的全球生物技术公司，今日宣布达成一项研究合作和独家选择权及许可协议。...
View ArticleClik here to view.
ソティオとバイオサイトジェン、ADCパイプラインを拡大するためにマルチターゲット抗体契約を締結
プラハ&北京 （ビジネスワイヤ） — PPFグループの臨床段階向けバイオ医薬品会社であるソティオ・バイオテックと、新規抗体医薬品の発見に取り組むグローバルバイオテクノロジー会社であるバイオサイトジェン（HKEX: 02315）は、研究協力、独占オプション契約およびライセンス契約について発表しました。...
View ArticleClik here to view.
Propanc Biopharma’s CSO Predicts PRP Could Solve Problem That Impacts...
MELBOURNE, Australia Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and...
View ArticleClik here to view.
ICH and CDISC Collaborate to Support the Maintenance and Governance Process...
AUSTIN, Texas & GENEVA The International Council for Harmonisation (ICH) M11 Expert Working Group (EWG) (Clinical electronic Structured Harmonized Protocol (CeSHarP) has developed a clinical...
View ArticleClik here to view.
ベイジーン、アーロン・ローゼンバーグ氏を最高財務責任者に任命
カリフォルニア州、サンマテオ （ビジネスワイヤ） — グローバル・オンコロジー企業のベイジーン（NASDAQ：BGNE；HKEX：06160；SSE：688235）は、アーロン・ローゼンバーグ氏を7月22日付で最高財務責任者（CFO）に任命したことを発表しました。ローゼンバーグ氏はジュリア・ワンの後任となります。ワンは引継ぎのために8月までベイジーンに在籍し、退職後は外部の機会を追求します。...
View ArticleClik here to view.
Equillium Announces Second Quarter 2024 Estimated Cash and Investments Balance
LA JOLLA, Calif. Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced...
View ArticleClik here to view.
European Medicines Agency Accepts Deciphera’s Marketing Authorization...
OSAKA, Japan & WALTHAM, Mass. Ono Pharmaceutical, Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) today announced that the European Medicines Agency (EMA) has accepted...
View ArticleClik here to view.
Gilead and the Elton John AIDS Foundation Announce Additional Five Years of...
FOSTER CITY, Calif. Gilead Sciences, Inc. (Nasdaq: GILD) and the Elton John AIDS Foundation (EJAF) today announced a five-year extension of the RADIAN® partnership to help meet the needs of the most...
View ArticleClik here to view.
PharmaEssentia Appoints Beth A. Krewson as Head of Legal
BURLINGTON, Mass. PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven...
View ArticleClik here to view.
BCF, BREF and TBG Companies Seek Global Financial Support to Establish 1000s...
WASHINGTON Dr. Krishnan Suthanthiran is the Founder and President of the Best Cure Foundation (BCF), a non-profit 501(c)(3) corporation established in Springfield, Virginia, USA, in 2007. He also...
View ArticleClik here to view.
ベイジーン、米国に生物製剤製造および臨床研究開発の旗艦施設を開設し、世界のより多くの患者に医薬品を届けるためのグローバルな拡大を継続
ニュージャージー州ホープウェル （ビジネスワイヤ） — がん領域専門のグローバル製薬企業であるベイジーン（NASDAQ: BGNE; HKEX: 06160; SSE:...
View ArticleClik here to view.
InnoCare Announces First Subject Dosed in Clinical Trial of TYK2 Inhibitor...
BEIJING InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, today announced that the first subject has been...
View ArticleClik here to view.
PROTEINA Co., Ltd. Announces Breakthrough Research Published in Nature...
SEOUL, South Korea PROTEINA Co., Ltd., in collaboration with Seoul National University (SNU) and Seoul National University Hospital (SNUH), has announced the publication of its latest research in...
View ArticleClik here to view.
Dren Bio Announces Strategic Collaboration with Novartis to Develop Novel...
FOSTER CITY, Calif. Dren Bio, Inc. (“Dren Bio” or the “Company”), a privately held, clinical-stage biopharmaceutical company developing antibody therapeutics for cancer, autoimmune, and other...
View ArticleClik here to view.
Sunflower Therapeutics Announces SK bioscience’s $2M SAFE Investment
MEDFORD, Mass. & SEONGNAM, South Korea Sunflower Therapeutics, a public benefit corporation transforming global access to protein manufacturing capacity for diverse applications, today announced...
View ArticleClik here to view.
ドレン・バイオがノバルティスとの戦略的提携を発表、がんに対する新規標的骨髄エンゲイジャーの開発へ
カリフォルニア州フォスターシティー （ビジネスワイヤ） — がんや自己免疫疾患などの重篤疾患の抗体治療薬を開発する非上場・臨床段階のバイオ医薬品企業であるドレン・バイオ・インク（以下「ドレン・バイオ」または「当社」）は、ノバルティスAG（NYSE:...
View ArticleClik here to view.
Sunbird Bio Presents Latest Data Reinforcing Significance of Blood-Based Tau...
CAMBRIDGE, Mass. & SINGAPORE Sunbird Bio, a biotechnology company developing proprietary blood-based technologies to improve diagnosis and treatment of neurological disorders and early-stage...
View Article